Zai Lab Limited
ZLAB
$16.59
$0.694.34%
Headlines
4/30/2024
-
Tickeron - Stocks
4/30/2024
-
Simply Wall St
4/27/2024
-
Tickeron - Stocks
4/26/2024
-
ETF Channel
4/26/2024
-
Zolmax
4/26/2024
-
Tickeron - Stocks
4/25/2024
-
Tickeron - Technical Analysis
4/24/2024
-
Tickeron - Stocks
4/23/2024
-
Tickeron - Stocks
4/23/2024
-
Tickeron - Stocks
4/20/2024
-
Tickeron - Technical Analysis
4/19/2024
-
The Fly
4/19/2024
-
Tickeron - Stocks
4/19/2024
-
Tickeron - Stocks
4/18/2024
-
Tickeron - Stocks
4/18/2024
-
Ticker Report
4/17/2024
-
Tickeron - Stocks
4/17/2024
-
Ticker Report
4/17/2024
-
Ticker Report
4/16/2024
-
SeekingAlpha
4/16/2024
-
Tickeron - Stocks
Zai Lab to Announce First Quarter 2024 Financial Results and Recent Corporate Updates on May 8, 2024
4/15/2024
-
Business Wire
4/12/2024
-
Ticker Report
4/11/2024
-
The Fly
4/11/2024
-
Business Wire
Filings
Tuesday, February 27, 2024
Sunday, December 31, 2023
Week of May 6 and 10 (est)
Price History
Corporate Info
86 21 6163 2588
Jinchuang Plaza
Building 1, Fourth Floor - 4560 Jinke Road
Pudong Shanghai, 201210
Building 1, Fourth Floor - 4560 Jinke Road
Pudong Shanghai, 201210
Business Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally...
more